行情

CYTO

CYTO

Altamira Therapeutics Ltd
NASDAQ

实时行情|Nasdaq Last Sale

2.160
-0.090
-4.00%
盘后: 2.140 -0.02 -0.93% 17:19 09/17 EDT
开盘
2.180
昨收
2.250
最高
2.262
最低
2.105
成交量
20.40万
成交额
--
52周最高
6.60
52周最低
0.7255
市值
2,816.31万
市盈率(TTM)
-1.4439
分时
5日
1月
3月
1年
5年
Altamira Therapeutics 将出席 HC Wainwright 第 23 届年度全球投资会议
HAMILTON, BERMUDA / ACCESSWIRE / September 9, 2021 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics, today announc...
ACCESSWIRE · 09/09 12:30
Altamira Therapeutics 提供业务更新并报告 2021 年上半年财务业绩
(NASDAQ:CYTO) ("Altamira" or the "Company"), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics, today provided a business update and announced first half 2021 ...
ACCESSWIRE · 09/08 12:30
Altamira Therapeutics 报告了 Bentrio 鼻喷雾剂对 A 型流感病毒的影响;表示“在预防和治疗流感感染方面,人鼻上皮模型中的病毒滴度显着降低”
Significant reduction of viral titer in human nasal epithelium model both in prevention and treatment of influenza infection (p<0.01) New data demonstrate protective effects in viral infections beyond
Benzinga · 08/06 13:01
Altamira Therapeutics 报告了 Bentrio(TM) 喷鼻剂对甲型流感病毒 (H1N1) 的保护作用
* Significant reduction of viral titer in human nasal epithelium model both in prevention and treatment of influenza infection (p<0.01) * New data demonstrate protective effects in viral infections beyond SARS-CoV-2HAMILTON, BERMUDA / ACCESSWIRE / August 6...
ACCESSWIRE · 08/06 13:00
Altamira Therapeutics 宣布推出专用于 Bentrio(TM) 鼻腔喷雾剂的网站
HAMILTON, BERMUDA / ACCESSWIRE / August 3, 2021 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics, today announced ...
ACCESSWIRE · 08/03 13:01
Auris Medical 推出新的企业网站
Auris Medical Holding (EARS) announces the launch of its newly-designed corporate website www.aurismedical.com. "...the new website reflects the company’s recent strategic move into RNA therapeutics, while highlighting the exciting prospects for its
Seekingalpha · 07/16 13:07
Auris Medical 宣布推出新的公司网站
Hamilton, Bermuda, July 15, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics, today announced the launch of ...
GlobeNewswire · 07/16 13:00
Auris Medical 的 Bentrio 鼻腔喷雾剂显示鼓励在预防、减轻 COVID-19 方面采取临床前行动
Benzinga · 07/14 15:40
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解CYTO最新的财务预测,通过CYTO每股收益,每股净资产,每股现金流等数据分析Altamira Therapeutics Ltd近期的经营情况,然后做出明智的投资选择。
分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测CYTO价格均价为14.69,最高价位14.69,最低价为14.69。
EPS
机构持股
总机构数: 20
机构持股: 143.10万
持股比例: 10.97%
总股本: 1,303.85万
类型机构数股数
增持
4
2.65万
建仓
4
1.09万
减持
3
6.82万
平仓
8
15.98万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
+0.49%
制药与医学研究
-0.10%
高管信息
Chairman/Chief Executive Officer/Director
Thomas Meyer
Non-Executive Vice Chairman
James Healy
Chief Financial Officer/Primary Contact
Hernan Levett
General Counsel
Anne Zoller
Other/IR Contact Officer
Cindy McGee
Other
Andrea Braun
Other
Thomas Jung
Other
Bettina Stubinski
Director
Mats Blom
Director
Alain Munoz
Non-Executive Independent Director
Oliver Kubli
Non-Executive Independent Director
Berndt Modig
Non-Executive Independent Director
Armando Anido
Non-Executive Independent Director
Calvin Roberts
Non-Executive Independent Director
Wolfgang Arnold
暂无数据
CYTO 简况
Auris Medical Holding AG是一家瑞士的生物技术公司,专注于神经病学、鼻科、过敏和中枢神经系统(CNS)疾病的治疗和医疗设备的开发和商业化。该公司活跃于三个领域,如:开发用于肝外治疗靶点的寡核苷酸-OligoPhore平台;预防空气传播病毒和过敏原的鼻喷剂Bentrio或治疗眩晕的AM-125;开发治疗耳鸣的Keyzilen或听力损失的Sonsuvi的鼓室内治疗方法。

微牛提供Altamira Therapeutics Ltd(NASDAQ-CYTO)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的CYTO股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易CYTO股票基本功能。